IP Library Patent Application 11722072
Patent Application
App. No. 11/722,072

USE OF A DIHYDROIMIDAZOPYRAZOINE DERIVATIVE FOR TREATING OR PREVENTING PAIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/722,072
Abstract

The invention relates to the use of (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-yl]-2-oxoethylamine or an pharmaceutically acceptable salt thereof for preparing a drug for preventing or treating pain.

Claims (8)

1 . A method of preventing or treating pain comprising administering a medicament comprising (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[ 1 , 2 -α]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-α]pyrazin-7(8H)-yl]-2-oxoethylamine or a pharmaceutically acceptable salts thereof.

2 . The method of claim 1 , wherein the pain is caused by a neuropathy and/or an inflammation.

3 . The method of claim 1 , wherein the pain is caused by an anti-cancer treatment.

4 . The method of claim 3 , wherein the anti-cancer treatment is a treatment by chemotherapy or radiotherapy.

5 . The method of claim 1 , wherein the pain is caused by a cancer.

6 . The method of claim 1 , characterized in that wherein the pain is associated with an inflammation, chronic or otherwise, chronic diseases other than cancer, radiculopathies, adiposis dolorosa, migraine, chronic diseases, fibromyalgia, algoneurodystrophy or complex regional pain syndrome, cerebrovascular accidents, arthrosis, arthritis, diabetic neuropathies or following HIV, sciatica, painful muscular contractions, intoxication, burns, post- herpetic neuralgias, thalamic lesions or multiple sclerosis.

7 . The method of claim 1 , wherein the pain is caused by a dermal lesion or by pre- and/or post-operative pain.

8 . The method of claim 5 , wherein the pain caused by cancer is pain associated with cancers of the prostate, breast, ovaries, pancreas, colon, lung or skin.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED ON REEL 023640 FRAME 0166. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 23, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 038772/0729 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 023638 FRAME: 0555. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 23, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 038779/0043 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME. NEED TO ADD S.A.S. TO END OF NAME IPSEN PHARMA. CORRECT NAME SHOULD SHOW AS IPSEN PHARMA S.A.S. PREVIOUSLY RECORDED ON REEL 023638 FRAME 0555. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT NAME SHOULD SHOW AS IPSEN PHARMA S.A.S.. Recorded Jan 12, 2010
From: S.C.R.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 023763/0615 →
CHANGE OF NAME Recorded Dec 11, 2009
From: S.C.R.A.S.
To: IPSEN PHARMA
Reel/Frame 023638/0555 →
CHANGE OF ADDRESS Recorded Dec 11, 2009
From: S.C.R.A.S.
To: S.C.R.A.S.
Reel/Frame 023640/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2007
From: AUGUET, MICHAEL; FAVRE, CHRISTINE; PREVOST, GREGOIRE; CHABRIER DE LASSAUNIERE, PIERRE-ETIENNE
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES
Reel/Frame 019447/0121 →